Global Clot Management Devices Market (2016 - 2022)

Global Clot Management Devices Market (2016 - 2022)

  • January 2017 •
  • 160 pages •
  • Report ID: 4687934 •
  • Format: PDF
Blood Clotting also known as coagulation is the body’s response to an injury to prevent bleeding. It prevents excessive bleeding when the blood vessels are injured. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot forms in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely. Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT. As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure.

Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters. Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres.

Based on region, Clot Management Devices market is segmented into North America (US, Canada, Mexico and Rest of North America), Europe (Germany, UK, France, Russia, Spain, Italy and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia-Pacific) and Latin America, and Middle East & Africa. North America remained the dominant region in the global Clot Management Devices market in 2015. Asia-Pacific would witness promising CAGR during the forecast period (2016-2022).

The report covers the analysis of key stake holders of the Clot Management Devices market. Key companies profiled in the report include Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.